Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Erin
P J Barnes
T T Hansel

Showing results (1-10 of 881) with videos related to

Pageof 89
Sort By:
Current Drug Targets. Inflammation and Allergy|October 17, 2003
Eotaxin receptor (CCR3) antagonism in asthma and allergic diseaseE M Erin, T J Williams, P J Barnes, et al.
Current Allergy and Asthma Reports|March 20, 2002
Novel drugs for treating asthmaT T Hansel, P J Barnes
Expert Opinion on Investigational Drugs|November 4, 2000
Novel therapy for COPDM J Leckie, S A Bryan, T T Hansel, et al.
Expert Opinion on Investigational Drugs|November 4, 2000
Novel therapy for asthmaS A Bryan, M J Leckie, T T Hansel, et al.
Allergy|November 4, 2005
Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challengeE M Erin, B R Leaker, A S Zacharasiewicz, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 6, 2006
Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challengeE M Erin, A S Zacharasiewicz, G C Nicholson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 25, 2006
Effects of a reversible beta-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responsesE M Erin, B R Leaker, A Zacharasiewicz, et al.
Drug News & Perspectives|June 24, 2003
Smoking-related lung disease: prospects for new drug therapyT T Hansel
Current Opinion in Pulmonary Medicine|June 2, 2001
New treatments for asthma: current and future aspectsT T Hansel
Methods in Molecular Medicine|February 22, 2011
Measurement of granulocyte pharmacodynamics in whole blood by flow cytometryS A Bryan, M J Leckie, G Jenkins, et al.
Pageof 89

Showing results (1-10 of 881) with videos related to

Sort By:
Pageof 89
Current Drug Targets. Inflammation and Allergy|October 17, 2003
Eotaxin receptor (CCR3) antagonism in asthma and allergic diseaseE M Erin, T J Williams, P J Barnes, et al.
Current Allergy and Asthma Reports|March 20, 2002
Novel drugs for treating asthmaT T Hansel, P J Barnes
Expert Opinion on Investigational Drugs|November 4, 2000
Novel therapy for COPDM J Leckie, S A Bryan, T T Hansel, et al.
Expert Opinion on Investigational Drugs|November 4, 2000
Novel therapy for asthmaS A Bryan, M J Leckie, T T Hansel, et al.
Allergy|November 4, 2005
Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challengeE M Erin, B R Leaker, A S Zacharasiewicz, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 6, 2006
Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challengeE M Erin, A S Zacharasiewicz, G C Nicholson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 25, 2006
Effects of a reversible beta-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responsesE M Erin, B R Leaker, A Zacharasiewicz, et al.
Drug News & Perspectives|June 24, 2003
Smoking-related lung disease: prospects for new drug therapyT T Hansel
Current Opinion in Pulmonary Medicine|June 2, 2001
New treatments for asthma: current and future aspectsT T Hansel
Methods in Molecular Medicine|February 22, 2011
Measurement of granulocyte pharmacodynamics in whole blood by flow cytometryS A Bryan, M J Leckie, G Jenkins, et al.
Pageof 89